Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis | SpringerLink
survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Frontiers | Treatment and survival analysis for 40-year SEER data on upper esophageal cancer
VYXEOS® Efficacy - Phase 3 Trial Data vs 7+3 | VYXEOS® (daunorubicin and cytarabine)
VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer | 2 Minute Medicine
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
MARGENZA® Clinical Results
Cancers | Free Full-Text | Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Median overall survival according to changes in CA 19-9 | Open-i
Kaplan-Meier survival analysis
NEJM on X: "Nivolumab increases median overall survival by 5.4 months in adv renal cell cancer. #ECC2015 http://t.co/9DSZcnbnAs http://t.co/22qcFuEfzN" / X
Kaplan–Meier survival curves. (A) Median overall survival was... | Download Scientific Diagram
Median Survival Time - an overview | ScienceDirect Topics
GraphPad Prism 10 Statistics Guide - Determining the median followup time
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma | NEJM
Survival (time to event) data: median survival times | The BMJ
Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research
Ambiguities in computing the median survival time. - FAQ 44 - GraphPad
Biology | Free Full-Text | Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with
